Pharma and Biotech
Final Results | 25-Apr-2024 | 07:00 | RNS |
Total Voting Rights | 28-Mar-2024 | 07:00 | RNS |
Placing to Raise US$4.2 million | 29-Feb-2024 | 07:00 | RNS |
CBR Brain Delivery | 16-Feb-2024 | 07:00 | RNS |
CBR Intranasal Delivery | 14-Feb-2024 | 07:00 | RNS |
FDA Consents to Phase I Trials of HEMO-CAR-T | 09-Feb-2024 | 07:00 | RNS |
Approval and Issuance of U.S. Conditioning Patent | 02-Feb-2024 | 07:00 | RNS |
Submission of Complete Response to Clinical Hold | 16-Jan-2024 | 07:00 | RNS |
HEMO-CAR-T Process Qualification Run Completed | 08-Jan-2024 | 07:00 | RNS |
Placing to Raise £534,375 | 28-Nov-2023 | 12:19 | RNS |
CBR Expanded to Treatment of Cancer | 27-Nov-2023 | 07:00 | RNS |
Lentivirus Re-manufacturing Completed | 15-Nov-2023 | 07:00 | RNS |
Total Voting Rights | 31-Oct-2023 | 07:00 | RNS |
Half-year Report | 28-Sep-2023 | 12:28 | RNS |
Strategic Investment from Prevail Partners, LLC | 18-Sep-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 1.48p |
Change Today | -0.040p |
% Change | -2.64 % |
52 Week High | 3.96 |
52 Week Low | 1.17 |
Volume | 2,259,529 |
Shares Issued | 1,341.82m |
Market Cap | £19.79m |
RiskGrade | 340 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:24 | 12,570 @ 1.49p |
16:04 | 6,140 @ 1.49p |
15:38 | 201 @ 1.50p |
14:39 | 265 @ 1.50p |
14:32 | 649 @ 1.45p |
You are here: research